Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Beauty Health (SKIN) Long-Term Debt Repayments (2024 - 2025)

Beauty Health (SKIN) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $18.4 million as the latest value for Q2 2025.

Quarterly Long-Term Debt Repayments fell 81.28% to $18.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Dec 2025, down 88.21% year-over-year, with the annual reading at $18.4 million for FY2025, 88.23% down from the prior year.
Long-Term Debt Repayments for Q2 2025 was $18.4 million at Beauty Health, down from $98.3 million in the prior quarter.
The five-year high for Long-Term Debt Repayments was $98.3 million in Q2 2024, with the low at $18.4 million in Q2 2025.